Significant Publications on Infectious Diseases Pharmacotherapy in 2024 [0.03%]
2024年传染病药物治疗领域的重要文献回顾
Lauren Lee,Yao-Hsuan Huang,Hiba Al Shaikhli et al.
Lauren Lee et al.
Purpose: To provide a summarization of the most significant infectious diseases (ID) pharmacotherapy articles published in peer-reviewed literature in 2024. Summary: Members of the Houston Infectious Diseases Network (HIDN) nominated notabl...
Impact of Pharmacist Consultations in Management of Type 1 Diabetes in a Primary Care Clinic: A Retrospective Cohort Study [0.03%]
药师在基层医疗机构管理1型糖尿病中的咨询作用：回顾性队列研究
Jacob Burger,Rick Hess
Jacob Burger
Introduction: Type 1 diabetes mellitus (T1DM) is a condition requiring lifelong insulin therapy and specialized care. Access to endocrinologists remains limited, leaving many primary care providers (PCPs) to manage insulin therapies and dia...
Case Report of Treatment of Polymicrobial Bacteremia Caused by Carbapenem-Resistant Klebsiella pneumoniae, and Bacillus Species in an Immunocompetent Patient With Meropenem-Vaborbactam [0.03%]
免疫competent患者使用美罗培南-法硼巴坦治疗由碳青霉烯耐药肺炎克雷伯菌和芽孢杆菌引起的复杂多元细菌血流感染的病例报告
Zoey Zagoria,John Cerenzio,Justin Andrade
Zoey Zagoria
Klebsiella pneumoniae carbapenemases (KPCs) are the most common carbapenemases in the United States. The Infectious Disease Society of America (IDSA) recommends meropenem-vaborbactam, ceftazidime-avibactam, or imipenem-cilastatin-relebactam...
Intersecting Burdens: Type 2 Diabetes Diagnosis, Risk, and Pharmacological Management Among People Living With HIV [0.03%]
HIV阳性人群中的二型糖尿病诊断、风险及药物治疗状况分析——双重负担视角
Rachel Arnold,Briann Fischetti,Maria Longo
Rachel Arnold
Many patients living with human immunodeficiency virus (HIV) may develop long-term metabolic complications due to various reasons, such as chronic inflammation and adverse effects from antiretrovirals (ARVs). A particularly significant meta...
Effectiveness of Pharmacist-Led Provider Education on Antimicrobial Discharge Prescriptions for Common Infections [0.03%]
药师主导的抗菌药物出院带药教育项目对常见感染的影响研究
Angela Basir,Ankit Gohel,Jason Brady et al.
Angela Basir et al.
Background: Several strategies described in the literature regarding the role of pharmacist-led educational interventions to healthcare providers, however, evidence available on the role of education in the Emergency Department (ED) setting...
Appropriateness of Empiric Antimicrobial Therapy for Community Onset Sepsis With Bacteremia in the Emergency Department: A Multidisciplinary Approach [0.03%]
急诊科医务人员对社区获得性感染性休克经验性抗菌治疗合理性的多学科研究
Salma Abdelwahab,Yanina Dubrovskaya,Kassandra Marsh et al.
Salma Abdelwahab et al.
Background: Optimizing early antimicrobial therapy and incorporating clinical pharmacists into sepsis treatment strategies are essential for improving patient outcomes. Objective: To examine the appropriateness of empiric antimicrobial sele...
Oral Ibuprofen Versus Intramuscular Ketorolac for Acute Musculoskeletal Back Pain in the Emergency Department: A Prospective Analysis [0.03%]
急性肌肉骨骼背痛的口服布洛芬和肌内注射酮咯酸的疗效比较：一项前瞻性分析
Myroslava Sharabun,Robert O&#x;Connell,Howard Greller et al.
Myroslava Sharabun et al.
Ibuprofen and ketorolac are nonsteroidal anti-inflammatory drugs (NSAIDs) commonly used to treat acute back pain in the Emergency Department (ED). Data comparing pain relief between oral and intramuscular administration at their proposed ce...
Assessing the Value of Biosimilars: A Cost-Effectiveness Approach for Managed Care Organizations [0.03%]
生物仿制药的价值评估：管理式医疗组织的 cost-effectiveness 方法
Vishwanauth Persaud,Reanne Bernstein,Albert Wertheimer
Vishwanauth Persaud
Biologic medications are essential for treating chronic diseases but come with high costs, prompting interest in biosimilars as more affordable alternatives. Biosimilars are highly similar to FDA-approved biologics in terms of safety and ef...
Evaluation of Antibiotic Selection in the Emergency Department Following the Implementation of an Infectious Source-Specific Order Set [0.03%]
感染源特定医嘱集实施后的急诊抗生素选择评估
Jon Derringer,Cody Null,Jared Heiles et al.
Jon Derringer et al.
Emergency department (ED) practitioners frequently prescribe antibiotics for sepsis and other infections, with quality and performance metrics often influencing broad-spectrum antibiotic selection. This study objective was to evaluate impro...
Key Articles and Guidelines in the Management of Chronic Coronary Disease [0.03%]
慢性冠状动脉疾病的管理关键文章和指南
Dave L Dixon,Tomasz Jurga,Michael Kelly et al.
Dave L Dixon et al.
Cardiovascular disease remains the leading cause of death; however, advances in the acute management of cardiovascular events have resulted in a greater number of patients who require chronic management to prevent future events. The care of...